Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-23 7:39 pm Purchase |
2025-03-31 | 13G | Novo Nordisk A/S NVO |
BlackRock Inc. BLK |
177,801,601 5.200% |
177,801,601 (New Position) |
Filing History |
| 2024-02-06 3:14 pm Purchase |
2023-12-31 | 13G | Novo Nordisk A/S NVO |
BlackRock Inc. BLK |
236,598,124 6.900% |
122,845,158 (+107.99%) |
Filing |
| 2023-02-23 5:06 pm Sale |
2022-12-31 | 13G | Novo Nordisk A/S NVO |
BlackRock Inc. BLK |
227,505,932 6.500% |
-19,908,398 (-8.05%) |
Filing |
| 2022-01-31 5:59 pm Purchase |
2021-12-31 | 13G | Novo Nordisk A/S NVO |
BlackRock Inc. BLK |
247,414,330 7.000% |
16,539,332 (+7.16%) |
Filing |
| 2021-01-29 5:21 pm Purchase |
2020-12-31 | 13G | Novo Nordisk A/S NVO |
BlackRock Inc. BLK |
230,874,998 6.400% |
14,917,942 (+6.91%) |
Filing |